The Federal Register published notice 2020-26133, attributed to FDA and its parent HHS department, on 2020-11-25. Its official title is “Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin. 1
This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. 1